WO1998038985A3 - Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases - Google Patents
Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases Download PDFInfo
- Publication number
- WO1998038985A3 WO1998038985A3 PCT/EP1998/001240 EP9801240W WO9838985A3 WO 1998038985 A3 WO1998038985 A3 WO 1998038985A3 EP 9801240 W EP9801240 W EP 9801240W WO 9838985 A3 WO9838985 A3 WO 9838985A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carvedilol
- preventive
- medicament
- inflammatory diseases
- therapeutic treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU69203/98A AU6920398A (en) | 1997-03-06 | 1998-03-05 | Medicament for preventive and therapeutic treatment of inflammatory diseas es |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP97/51473 | 1997-03-06 | ||
JP9051473A JPH10251147A (en) | 1997-03-06 | 1997-03-06 | Preventing and/or treating agent for inflammatory disease |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998038985A2 WO1998038985A2 (en) | 1998-09-11 |
WO1998038985A3 true WO1998038985A3 (en) | 1998-12-23 |
Family
ID=12887931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1998/001240 WO1998038985A2 (en) | 1997-03-06 | 1998-03-05 | Use of carvedilol for the manufacture of a medicament for preventive and therapeutic treatment of inflammatory diseases |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPH10251147A (en) |
AU (1) | AU6920398A (en) |
WO (1) | WO1998038985A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001292897A1 (en) * | 2000-09-21 | 2002-04-02 | Richard Agustin Bond | Novel therapy |
EP1677778A2 (en) | 2003-10-09 | 2006-07-12 | Inverseon, Inc. | Method of treating airway diseases with beta-adrenergic inverse agonists |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012178A1 (en) * | 1992-12-01 | 1994-06-09 | Smithkline Beecham Corporation | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
-
1997
- 1997-03-06 JP JP9051473A patent/JPH10251147A/en active Pending
-
1998
- 1998-03-05 AU AU69203/98A patent/AU6920398A/en not_active Abandoned
- 1998-03-05 WO PCT/EP1998/001240 patent/WO1998038985A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994012178A1 (en) * | 1992-12-01 | 1994-06-09 | Smithkline Beecham Corporation | Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds |
Non-Patent Citations (4)
Title |
---|
GIORA Z. FEUERSTEIN ET AL.: "Carvedilol: Preclinical profile and rationale for its use in hypertension, coronary syndromes, and congestive haert failure", CARDIOVASCULAR REVIEWS & REPORTS, vol. 17, no. 10, 1996, pages 27 - 38, XP002072749 * |
GIORA.Z.FEUERSTEIN ET AL.: "Carvedilol update III: Rationale for use in congestive heart failure", DRUGS OF TODAY, vol. 31, no. suppl. F, 1995, pages 1 - 23, XP002072748 * |
PETER LIU ET AL.: "Viral myocarditis: Balance between viral infection and immune response", CAN.J.CARDIOL., vol. 12, no. 10, 1996, pages 935 - 943, XP002072747 * |
VINCENT R. ZALES ET AL.: "Endocarditis, pericarditis and myocarditis", PEDIATRIC ANNALS, vol. 26, no. 2, February 1997 (1997-02-01), pages 116 - 121, XP002072750 * |
Also Published As
Publication number | Publication date |
---|---|
WO1998038985A2 (en) | 1998-09-11 |
AU6920398A (en) | 1998-09-22 |
JPH10251147A (en) | 1998-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ514574A (en) | Novel method of treatment | |
AU3990797A (en) | Sustained release formulation | |
NO971206D0 (en) | Prolonged-frigjöringsformulering | |
NO20022014D0 (en) | Controlled release of hydrocodone formulations | |
ITMI961152A0 (en) | THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ACTIVE INGREDIENT, ESTROGEN OR PROGESTIN OR MIXTURES THEREOF | |
EP1029540A3 (en) | Use of droloxifene for the treatment of cardiovascular diseases | |
AU3153097A (en) | Pharmaceutical for treatment of neurological and neuropsychiatric disorders | |
AU7031500A (en) | Therapeutic quinazoline compounds | |
UY26372A1 (en) | "IMIDAZO-3-IL-AMINAS BICÍCLICAS PROCEDURE FOR ITS PREPARATION AND DRUGS THAT CONTAIN THEM" | |
WO2003015779A3 (en) | Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole | |
CA2382387A1 (en) | Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure | |
WO2001098279A3 (en) | Bis-arylsulfones | |
NO994165L (en) | Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness | |
WO1999004772A3 (en) | Use of levobupivacaine | |
CA2253130A1 (en) | A medicament for treating obesity and improving lipid metabolism | |
AU1495595A (en) | Sustained-release dosage forms of alfuzosin hydrochloride | |
MXPA02002452A (en) | Preventive and therapeutic agents for eye diseases. | |
EP1440691A3 (en) | Treatment of neurotic disorders | |
GR3025568T3 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. | |
AR023687A1 (en) | A COMPOSITION FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS AND THE USE OF A GLUTAMATE ANTAGONIST FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF EXTERNAL RETINA DISORDERS | |
AU2001258395A1 (en) | Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases | |
CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
NO981951L (en) | Pharmaceutical surface preparation for the treatment of autoimmune diseases | |
AP9901474A0 (en) | Pharmaceutical composition for treating viral diseases. | |
EP0842663A4 (en) | Ophthalmic preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 1998538161 Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |